NEW YORK, June 26, 2018 (GLOBE NEWSWIRE) -- The Law Offices of Vincent Wong announce that class actions have commenced on behalf of shareholders of the following companies. If you suffered a loss you have until the lead plaintiff deadline to request that the court appoint you as lead plaintiff.

Prothena Corporation (NASDAQ:PRTA)
Lead Plaintiff Deadline: July 16, 2018          
Class Period: October 15, 2015 and April 20, 2018

The complaint alleges that Prothena issued materially false and misleading statements and/or failed to disclose that: the relevant trial data showed that Prothena’s antibody NEOD001, designed to treat amyloid light chain amyloidosis (“AL amyloidosis”), was not an effective treatment; the Company made misleading comparisons of NEOD001’s “best response” rates against certain prior studies; and the Company touted Prothena’s ongoing Phase 1/2 study of NEOD001 as providing a strong basis for late-stage Phase 2b and Phase 3 studies of NEOD001, even though the full Phase 1/2 study data demonstrated that NEOD001 was not an effective treatment.

Get additional information: http://www.wongesq.com/pslra-c/prothena-corporation-2?wire=3.

Micro Focus International plc (NYSE:MFGP)
Lead Plaintiff Deadline: July 23, 2018
Class Period: September 1, 2017 and March 19, 2018; pursuant to the August 4 and August 22, 2017 Prospectuses

The complaint alleges that the Registration Statement and Prospectus filed for the Company’s Initial Public Offering contained materially false and misleading information and/or failed to disclose material information, and that Micro Focus made materially false and misleading statements and/or failed to disclose material information throughout the class period.

Get additional information: http://www.wongesq.com/pslra-c/micro-focus-international-plc?wire=3

Deutsche Bank Aktiengesellschaft (NYSE:DB)
Lead Plaintiff Deadline: August 6, 2018
Class Period: March 20, 2017 and March 30, 2018

The complaint alleges that Deutsche Bank's internal control environment and infrastructure were materially weak and deficient; and as a result, Deutsche Bank's statements about the Company's business and operations were materially false and misleading at all relevant times. Get additional information: http://www.wongesq.com/pslra-c/deutsche-bank-aktiengesellschaft-2?wire=3.

Vincent Wong, Esq. is an experienced attorney that has represented investors in securities litigations involving financial fraud and violations of shareholder rights. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Vincent Wong, Esq.
39 East Broadway
Suite 304
New York, NY 10002
Tel. 212.425.1140
Fax. 866.699.3880
E-Mail: vw@wongesq.com

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.